Agepha Pharma Fz Drug Patent Portfolio
Agepha Pharma Fz owns 1 orange book drug protected by 11 US patents Given below is the list of Agepha Pharma Fz's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10130585 | Methods of treating and/or preventing cardiovascular disease | 09 May, 2034 | Active |
| US10206891 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent | 01 Nov, 2033 | Active |
| US10265281 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | 01 Nov, 2033 | Active |
| US10842762 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent | 01 Nov, 2033 | Active |
| US11026899 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | 01 Nov, 2033 | Active |
| US11026900 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | 01 Nov, 2033 | Active |
| US11026901 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | 01 Nov, 2033 | Active |
| US11944594 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | 01 Nov, 2033 | Active |
| US11944595 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | 01 Nov, 2033 | Active |
| US12233035 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent and statin | 01 Nov, 2033 | Active |
| US9744144 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent | 01 Nov, 2033 | Active |
Latest Legal Activities on Agepha Pharma Fz's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Agepha Pharma Fz.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 07 May, 2024 | US10842762 |
| Recordation of Patent eGrant | 02 Apr, 2024 | US11944595 |
| Patent eGrant Notification | 02 Apr, 2024 | US11944594 |
| Recordation of Patent eGrant | 02 Apr, 2024 | US11944594 |
|
Email Notification
Critical
| 02 Apr, 2024 | US11944595 |
| Mail Patent eGrant Notification | 02 Apr, 2024 | US11944595 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 02 Apr, 2024 | US11944595 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 02 Apr, 2024 | US11944594 |
| Mail Patent eGrant Notification | 02 Apr, 2024 | US11944594 |
|
Email Notification
Critical
| 02 Apr, 2024 | US11944594 |
|
Recordation of Patent Grant Mailed
Critical
| 02 Apr, 2024 | US11944595 |
| Patent eGrant Notification | 02 Apr, 2024 | US11944595 |
|
Recordation of Patent Grant Mailed
Critical
| 02 Apr, 2024 | US11944594 |
|
Email Notification
Critical
| 14 Mar, 2024 | US11944594 |
|
Email Notification
Critical
| 14 Mar, 2024 | US11944595 |
Agepha Pharma Fz's Family Patents
Agepha Pharma Fz Drug List
Given below is the complete list of Agepha Pharma Fz's drugs and the patents protecting them.
1. Lodoco
Lodoco is protected by 11 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10130585 | Methods of treating and/or preventing cardiovascular disease |
09 May, 2034
(8 years from now)
| Active |
| US10206891 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent |
01 Nov, 2033
(8 years from now)
| Active |
| US10265281 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
01 Nov, 2033
(8 years from now)
| Active |
| US10842762 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent |
01 Nov, 2033
(8 years from now)
| Active |
| US11026899 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
01 Nov, 2033
(8 years from now)
| Active |
| US11026900 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
01 Nov, 2033
(8 years from now)
| Active |
| US11026901 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
01 Nov, 2033
(8 years from now)
| Active |
| US11944594 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
01 Nov, 2033
(8 years from now)
| Active |
| US11944595 | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
01 Nov, 2033
(8 years from now)
| Active |
| US12233035 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent and statin |
01 Nov, 2033
(8 years from now)
| Active |
| US9744144 | Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent |
01 Nov, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lodoco's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List